insights_auto
Why is MYGN down 2.86%?
Dive Deeperchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
$4.08
arrow_downward
-2.86%(-0.12) 1D
$4.12
arrow_upward
+0.98% (+0.040)bedtimeAfter hours
Closed: Oct 13, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
$4.20
High
$4.22
Low
$4.05
Mkt. cap
390.25M
Avg. vol.
2.04M
Volume
0.00
52-wk high
$8.59
52-wk low
$2.74
EPS
-$1.20
Beta
1.64
Shares outstanding
95.65M
No. of employees
3K
Open
$4.20
High
$4.22
Low
$4.05
Mkt. cap
390.25M
Avg. vol.
2.04M
Volume
0.00
52-wk high
$8.59
52-wk low
$2.74
EPS
-$1.20
Beta
1.64
Shares outstanding
95.65M
No. of employees
3K
News stories
From web sources and news partners
RealClearMarkets
·
27 minutes ago
The Bigger Meaning of Italian Prosperity on Wall St
MarketBeat
·
9 minutes ago
Medline (NASDAQ:MDLN) Stock Has Average Target Price of $46.81
Seeking Alpha
·
1 hour ago
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
Investor's Business Daily
·
5 hours ago
Tech Futures Rise: Meta, AMD Lead 5 Buys; ASML, CPI Inflation Due
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com